
Metabolic
99% PureTirzepatide
Dual GIP/GLP-1 receptor agonist for metabolic research
Select size
$60.00/ 10mg
✓ View Certificate of Analysis (COA)
For research purposes only. Not for human consumption.
Mechanism of Action
A dual GIP/GLP-1 receptor agonist that activates two incretin pathways simultaneously for enhanced metabolic effects beyond single-receptor agonists.
How It Works
- 1
Activates GLP-1 receptors for insulin secretion and appetite suppression
- 2
Activates GIP receptors for enhanced insulin sensitivity and fat metabolism
- 3
Dual mechanism produces greater metabolic effects than GLP-1 alone
- 4
C20 fatty acid moiety enables albumin binding for weekly dosing
Key Research Benefits
- Dual incretin pathway
- Enhanced metabolic efficacy
- Weekly dosing potential
- Next-gen research compound
